{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:35:08Z","timestamp":1762544108864,"version":"3.32.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["EXCELES, Project No. LX22NPO5103","EXCELES, Project No. LX22NPO5103","EXCELES, Project No. LX22NPO5103"],"award-info":[{"award-number":["EXCELES, Project No. LX22NPO5103","EXCELES, Project No. LX22NPO5103","EXCELES, Project No. LX22NPO5103"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatitis B virus (HBV) infection can cause liver disease and lead to hepatocellular carcinoma (HCC). To better understand the factors involved in viral infection and pathogenesis and to develop novel therapies, it is crucial to investigate virus\u2013host interactions. HBV infection has been shown to increase the expression of the unconventional prefoldin RPB5 interactor (URI1), a cellular protein that promotes liver tumorigenesis and HCC metastasis. Our study investigated the role of URI1 in HBV infection in vitro. Although previous reports have suggested that URI1 may act as an HBV restriction factor, our results showed that URI1 silencing or overexpression did not affect HBV replication in HepG2-NTCP cells. In primary human hepatocytes, URI1 knockdown modestly reduced HBV markers but did not significantly alter acute infection. Supporting the premise that URI1 is a promising therapeutic target for HCC, our findings show that URI1 knockdown does not enhance HBV infection in an acute infection model. This suggests that URI1 may be a viable therapeutic target for patients with HBV-associated HCC without increasing HBV-related complications.<\/jats:p>","DOI":"10.1186\/s12985-024-02617-2","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T09:13:28Z","timestamp":1736500408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of the role of unconventional prefoldin RPB5 interactor (URI1) in hepatitis B virus infection"],"prefix":"10.1186","volume":"22","author":[{"given":"Karol\u00edna","family":"\u0160taflov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ale\u0161","family":"Z\u00e1bransk\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iva","family":"Pichov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"2617_CR1","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3390\/jpm13060964","volume":"13","author":"JF Schlaak","year":"2023","unstructured":"Schlaak JF. Current Therapy of Chronic Viral Hepatitis B, C and D. J Pers Med. 2023;13:964.","journal-title":"J Pers Med"},{"key":"2617_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ccell.2016.06.023","volume":"30","author":"S Bur\u00e9n","year":"2016","unstructured":"Bur\u00e9n S, Gomes AL, Teijeiro A, Fawal M-A, Yilmaz M, Tummala KS, et al. Regulation of OGT by URI in Response to Glucose Confers c-MYC-Dependent Survival Mechanisms. Cancer Cell. 2016;30:290\u2013307.","journal-title":"Cancer Cell"},{"key":"2617_CR3","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.ccell.2014.10.002","volume":"26","author":"KS Tummala","year":"2014","unstructured":"Tummala KS, Gomes AL, Yilmaz M, Gra\u00f1a O, Bakiri L, Ruppen I, et al. Inhibition of de novo NAD(+)\u2009synthesis by oncogenic URI causes liver tumorigenesis through DNA damage. Cancer Cell. 2014;26:826\u2013839.","journal-title":"Cancer Cell"},{"key":"2617_CR4","doi-asserted-by":"crossref","unstructured":"Tsuchiya H, Amisaki M, Takenaga A, Honjo S, Fujiwara Y, Shiota G. HBx and c-MYC cooperate to induce URI1 expression in HBV-Related Hepatocellular Carcinoma. Int J Mol Sci. 2019;20.","DOI":"10.3390\/ijms20225714"},{"key":"2617_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ccell.2016.05.020","volume":"30","author":"AL Gomes","year":"2016","unstructured":"Gomes AL, Teijeiro A, Bur\u00e9n S, Tummala KS, Yilmaz M, Waisman A, et al. Metabolic Inflammation-Associated IL-17A Causes Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma. Cancer Cell. 2016;30:161\u201375.","journal-title":"Cancer Cell"},{"key":"2617_CR6","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1038\/onc.2014.84","volume":"34","author":"J Zhang","year":"2015","unstructured":"Zhang J, Pan Y-F, Ding Z-W, Yang G-Z, Tan Y-X, Yang C, et al. RMP promotes venous metastases of hepatocellular carcinoma through promoting IL-6 transcription. Oncogene. 2015;34:1575\u201383.","journal-title":"Oncogene"},{"key":"2617_CR7","doi-asserted-by":"publisher","first-page":"40373","DOI":"10.18632\/oncotarget.16177","volume":"8","author":"W Zhou","year":"2017","unstructured":"Zhou W, Wang Q, Xu Y, Jiang J, Guo J, Yu H, et al. RMP promotes epithelial-mesenchymal transition through NF-\u03baB\/CSN2\/Snail pathway in hepatocellular carcinoma. Oncotarget. 2017;8:40373\u201388.","journal-title":"Oncotarget"},{"key":"2617_CR8","doi-asserted-by":"publisher","first-page":"6269","DOI":"10.1038\/s41467-023-41852-z","volume":"14","author":"Z Ding","year":"2023","unstructured":"Ding Z, Pan Y, Shang T, Jiang T, Lin Y, Yang C, et al. URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers. Nat Commun. 2023;14:6269.","journal-title":"Nat Commun"},{"key":"2617_CR9","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.7150\/ijbs.55689","volume":"17","author":"Y Xu","year":"2021","unstructured":"Xu Y, Ji Y, Li X, Ding J, Chen L, Huang Y, et al. URI1 suppresses irradiation-induced reactive oxygen species (ROS) by activating autophagy in hepatocellular carcinoma cells. Int J Biol Sci. 2021;17:3091\u2013103.","journal-title":"Int J Biol Sci"},{"key":"2617_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.7150\/ijbs.10275","volume":"10","author":"Q Wang","year":"2014","unstructured":"Wang Q, Xu Y, Zhou W, Zhong L, Wen Z, Yu H, et al. The Viral Oncoprotein HBx of Hepatitis B virus Promotes the Growth of Hepatocellular Carcinoma Through Cooperating with the Cellular Oncoprotein RMP. Int J Biol Sci. 2014;10:1181\u201392.","journal-title":"Int J Biol Sci"},{"key":"2617_CR11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ccell.2014.11.011","volume":"26","author":"I Mederacke","year":"2014","unstructured":"Mederacke I, Schwabe RF. NAD(+) supplementation as a novel approach to cURIng HCC? Cancer Cell. 2014;26:777\u20138.","journal-title":"Cancer Cell"},{"key":"2617_CR12","doi-asserted-by":"publisher","first-page":"7546","DOI":"10.1128\/MCB.18.12.7546","volume":"18","author":"D Dorjsuren","year":"1998","unstructured":"Dorjsuren D, Lin Y, Wei W, Yamashita T, Nomura T, Hayashi N, et al. RMP, a novel RNA polymerase II subunit 5-interacting protein, counteracts transactivation by hepatitis B virus X protein. Mol Cell Biol. 1998;18:7546\u201355.","journal-title":"Mol Cell Biol"},{"key":"2617_CR13","doi-asserted-by":"publisher","first-page":"e21936","DOI":"10.5812\/jjm.21936","volume":"8","author":"Q Zhou","year":"2015","unstructured":"Zhou Q, Huang F, Chen L, Chen E, Bai L, Cheng X, et al. RPB5-Mediating protein suppresses Hepatitis B Virus (HBV) transcription and replication by counteracting the transcriptional activation of Hepatitis B virus X protein in HBV Replication Mouse Model. Jundishapur J Microbiol. 2015;8:e21936.","journal-title":"Jundishapur J Microbiol"},{"key":"2617_CR14","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3390\/life13071527","volume":"13","author":"GS Lee","year":"2023","unstructured":"Lee GS, Purdy MA, Choi Y. Cell Culture systems for studying Hepatitis B and Hepatitis D Virus infections. Life. 2023;13:1527.","journal-title":"Life"},{"key":"2617_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.taap.2007.03.032","volume":"222","author":"KM Olsavsky","year":"2007","unstructured":"Olsavsky KM, Page JL, Johnson MC, Zarbl H, Strom SC, Omiecinski CJ. Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues. Toxicol Appl Pharmacol. 2007;222:42\u201356.","journal-title":"Toxicol Appl Pharmacol"},{"key":"2617_CR16","doi-asserted-by":"publisher","first-page":"e0186982","DOI":"10.1371\/journal.pone.0186982","volume":"12","author":"B Lubyova","year":"2017","unstructured":"Lubyova B, Hodek J, Zabransky A, Prouzova H, Hubalek M, Hirsch I, et al. PRMT5: a novel regulator of Hepatitis B virus replication and an arginine methylase of HBV core. PLoS ONE. 2017;12:e0186982.","journal-title":"PLoS ONE"},{"key":"2617_CR17","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1172\/JCI58847","volume":"122","author":"L Belloni","year":"2012","unstructured":"Belloni L, Allweiss L, Guerrieri F, Pediconi N, Volz T, Pollicino T, et al. IFN-\u03b1 inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J Clin Invest. 2012;122:529\u201337.","journal-title":"J Clin Invest"},{"key":"2617_CR18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1053\/j.gastro.2006.01.001","volume":"130","author":"T Pollicino","year":"2006","unstructured":"Pollicino T, Belloni L, Raffa G, Pediconi N, Squadrito G, Raimondo G, et al. Hepatitis B Virus replication is regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 histones. Gastroenterology. 2006;130:823\u201337.","journal-title":"Gastroenterology"},{"key":"2617_CR19","doi-asserted-by":"crossref","unstructured":"Kornyeyev D, Ramakrishnan D, Voitenleitner C, Livingston CM, Xing W, Hung M et al. Spatiotemporal analysis of Hepatitis B Virus X protein in primary human hepatocytes. J Virol. 2019;93.","DOI":"10.1128\/JVI.00248-19"},{"key":"2617_CR20","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/hep.27360","volume":"61","author":"BL Slagle","year":"2015","unstructured":"Slagle BL, Andrisani OM, Bouchard MJ, Lee CGL, Ou J-HJ, Siddiqui A. Technical standards for hepatitis B virus X protein (HBx) research. Hepatology. 2015;61:1416\u201324.","journal-title":"Hepatology"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02617-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-024-02617-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02617-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T10:03:49Z","timestamp":1736503429000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-024-02617-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2617"],"URL":"https:\/\/doi.org\/10.1186\/s12985-024-02617-2","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"assertion":[{"value":"25 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}